Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma [NA]
Clinical trial update on transcorneal electrical stimulation for visual field defects in open-angle glaucoma; recruitment is ongoing.
-
FDA approval · 2026-03-11FDA Approved: BRIMONIDINE TARTRATE — Original Application (Gland Pharma Limited)
FDA approved the original application for brimonidine tartrate ophthalmic solution from Gland Pharma Limited. The approval adds a generic op…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract [NA]
A clinical trial update announcing a recruiting study analyzing aqueous humor and ocular tissues in primary open-angle glaucoma and cataract…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve Conditions) [Phase 1]
A Phase 1 clinical trial update evaluating ER-100 for safety in patients with open-angle glaucoma or non-arteritic anterior ischemic optic n…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: UBM Evaluation After Combined Deep Sclerectomy With Trabeculotomy in Primary Open Angle Glaucoma
A clinical trial evaluating ultrasound biomicroscopy (UBM) after combined deep sclerectomy and trabeculotomy in primary open-angle glaucoma …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use [Phase 4]
A Phase 4 clinical trial from the University of Miami is evaluating biomarkers of ocular surface damage related to topical ocular hypotensiv…
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma [NA]
A terminated clinical trial evaluating the Nanodropper Device for reducing intraocular pressure in glaucoma and ocular hypertension has post…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea [NA]
Cairo University is conducting a clinical trial to evaluate whether lifestyle corrections can improve primary open-angle glaucoma in people …
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma [Phase 3]
A Phase 3 clinical trial evaluating the Ab Externo approach with the XEN-45 Gel Stent for open-angle glaucoma has completed, with updates on…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
This clinical trial update describes an observational study evaluating the updated inserter for the travoprost intracameral implant (75 mcg)…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma [NA]
This clinical trial aims to evaluate the safety and effectiveness of the iTrack canaloplasty device for open-angle glaucoma and is currently…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation [Phase 2]
Phase 2 single-site pilot trial of QLS-111 ophthalmic solution evaluating posterior perfusion and vessel dilation in non-proliferative diabe…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Conventional Non-Penetrating Deep Sclerectomy Versus Modified Subflap Mattress Suture in OAG [NA]
This completed clinical trial compares Conventional Non-Penetrating Deep Sclerectomy with a Modified Subflap Mattress Suture for Open-angle …
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: GORE Glaucoma Drainage Implant Clinical Study Dominican Republic [NA]
A GORE Glaucoma Drainage Implant trial in the Dominican Republic sponsored by W.L. Gore & Associates is currently active but not recruiting …
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries [NA]
This clinical trial status update shows a NOT_YET_RECRUITING study evaluating outcomes of goniotomy devices used during combined phacoemulsi…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: The Acute Effect of Exercise Type And Timing on Ambulatory Blood Pressure and Intra-Ocular Pressure in Individuals With Glaucoma (The ACHIEVE-project). [NA]
A clinical trial registered by KU Leuven evaluating the acute effects of exercise type and timing on ambulatory blood pressure and intraocul…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Direct vs Standard SLT for Glaucoma: A Noninferiority Trial [Phase 4]
This Phase 4 clinical trial compares Direct SLT to Standard SLT for open-angle glaucoma and ocular hypertension in a noninferiority design; …
-
EMA approval · 2026-02-06EMA Authorised: Azarga (brinzolamide;timolol maleate) — Novartis Europharm Limited
EMA authorised Azarga, a fixed-dose combination of brinzolamide and timolol, for open-angle glaucoma and ocular hypertension; applicant: Nov…
-
EMA approval · 2026-01-23EMA Authorised: Travatan (travoprost) — Novartis Europharm Limited
EU marketing authorisation granted for Travatan eye drops (travoprost) by Novartis Europharm Limited for glaucoma (open-angle) and ocular hy…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Comparing XEN®-63 Gel Stent and PRESERFLO® MicroShunt [NA]
A clinical trial to compare the XEN-63 Gel Stent with the PRESERFLO MicroShunt for open-angle glaucoma is currently recruiting at Universita…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Clinical Study Evaluating the Safety and Performance of the MIST Device for Intraocular Pressure Reduction in Patients With Primary Open-Angle Glaucoma [NA]
ClinicalTrials.gov reports that the MIST Device is being studied for safety and performance to reduce intraocular pressure in primary open-a…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone [Phase 3]
Phase 3 clinical trial evaluating whether adding a travoprost intraocular implant to the iStent Infinite provides advantages over iStent Inf…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Efficacy and Safety of iStent in Reducing Intraocular Pressure in Open-angle Glaucoma [NA]
A study is evaluating the efficacy and safety of the iStent device to reduce intraocular pressure in open-angle glaucoma, and the trial is c…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group
This update describes an observational PMCF study of the PRESERFLO MicroShunt for primary open-angle glaucoma, with no control group and not…
-
EMA approval · 2026-01-15EMA Authorised: Rhokiinsa (netarsudil) — Santen Oy
The EMA authorised Rhokiinsa (netarsudil) by Santen Oy for open-angle glaucoma and ocular hypertension.